Iyer R - Search Results

1

Octreotide and Lanreotide in Gastroenteropancreatic Neuroendocrine Tumors.

Pokuri VK, Fong MK, Iyer R. Pokuri VK, et al. Among authors: iyer r. Curr Oncol Rep. 2016 Jan;18(1):7. doi: 10.1007/s11912-015-0492-7. Curr Oncol Rep. 2016. PMID: 26743514 Review.

2

Epidermal growth factor receptor-directed therapy in esophageal cancer.

Pande AU, Iyer RV, Rani A, Maddipatla S, Yang GY, Nwogu CE, Black JD, Levea CM, Javle MM. Pande AU, et al. Among authors: iyer rv. Oncology. 2007;73(5-6):281-9. doi: 10.1159/000132393. Epub 2008 May 14. Oncology. 2007. PMID: 18477853 Review.

3

High-dose octreotide acetate for management of gastroenteropancreatic neuroendocrine tumors.

Chadha MK, Lombardo J, Mashtare T, Wilding GE, Litwin A, Raczyk C, Gibbs JF, Kuvshinoff B, Javle MM, Iyer RV. Chadha MK, et al. Anticancer Res. 2009 Oct;29(10):4127-30. Anticancer Res. 2009. PMID: 19846960 Free article.

4

The changing paradigm of treating pancreatic neuroendocrine tumors.

Iyer R, Reddy K. Iyer R, et al. J Natl Compr Canc Netw. 2011 Dec;9(12):1331-3. doi: 10.6004/jnccn.2011.0114. J Natl Compr Canc Netw. 2011. PMID: 22157553 Review. No abstract available.

5

Current understanding of the molecular biology of pancreatic neuroendocrine tumors.

Zhang J, Francois R, Iyer R, Seshadri M, Zajac-Kaye M, Hochwald SN. Zhang J, et al. Among authors: iyer r. J Natl Cancer Inst. 2013 Jul 17;105(14):1005-17. doi: 10.1093/jnci/djt135. Epub 2013 Jul 9. J Natl Cancer Inst. 2013. PMID: 23840053 Free PMC article. Review.

6

Carboplatin pharmacokinetics in a patient receiving hemodialysis.

Fong MK, Fetterly GJ Jr, McDougald LJ, Iyer RV. Fong MK, et al. Pharmacotherapy. 2014 Feb;34(2):e9-13. doi: 10.1002/phar.1354. Epub 2013 Sep 14. Pharmacotherapy. 2014. PMID: 24037992 Free PMC article.

7

Pant S, Martin LK, Geyer S, Wei L, Van Loon K, Sommovilla N, Zalupski M, Iyer R, Fogelman D, Ko AH, Bekaii-Saab T. Pant S, et al. Among authors: iyer r. Am J Clin Oncol. 2016 Dec;39(6):614-618. doi: 10.1097/COC.0000000000000108. Am J Clin Oncol. 2016. PMID: 25068471 Free PMC article. Clinical Trial.

8

Efficacy, Safety, and Potential Biomarkers of Sunitinib and Transarterial Chemoembolization (TACE) Combination in Advanced Hepatocellular Carcinoma (HCC): Phase II Trial.

Pokuri VK, Tomaszewski GM, Ait-Oudhia S, Groman A, Khushalani NI, Lugade AA, Thanavala Y, Ashton EA, Grande C, Fetterly GJ, Iyer R. Pokuri VK, et al. Among authors: iyer r. Am J Clin Oncol. 2018 Apr;41(4):332-338. doi: 10.1097/COC.0000000000000286. Am J Clin Oncol. 2018. PMID: 27014931 Clinical Trial.

9

Highlights in GEP-NETs From the 13th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease: Commentary.

Iyer R, Hatoum H. Iyer R, et al. Clin Adv Hematol Oncol. 2016 May;14(5 Suppl 7):17-9. Clin Adv Hematol Oncol. 2016. PMID: 27168109 No abstract available.

10

Ki67 score as a potential predictor in the selection of liver-directed therapies for metastatic neuroendocrine tumors: a single institutional experience.

Singla S, LeVea CM, Pokuri VK, Attwood KM, Wach MM, Tomaszewski GM, Kuvshinoff B, Iyer R. Singla S, et al. Among authors: iyer r. J Gastrointest Oncol. 2016 Jun;7(3):441-8. doi: 10.21037/jgo.2016.02.02. J Gastrointest Oncol. 2016. PMID: 27284478 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,585 results

Search Page

Filters